Document is current
Any future updates will be listed below
-
Authors
Law, Jeanna Wallenta
Campbell, Alicyn
Weller, Colin
Johanson, Colden
Broome, Ronda
Piault, Elisabeth
Izano, Monika https://orcid.org/0000-0003-1852-5342
Schrag, Andrew
Tran, Mary
Brown, Thomas D.
Kaplan, Henry G.
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 10 June 2022
Accepted: 4 September 2022
First Online: 6 October 2022
Declarations
:
: JWL, CJ, RB, MI, AS, MT, and TB are employees of Syapse, and JWL, MI, MT, and TB also hold Syapse stock. AC and EP are employees of AstraZeneca, and CW was employed by AstraZeneca at the time this study was conducted. AC has also received grants or contracts from Carevive, Takeda, Clinical Outcomes Solutions, and Lungevity. HK has received consulting fees from Syapse and also owns stock in Abbott Labs, Amgen, Bristol Myers Squibb, Merck, and Becton Dickinson. HK is an employee of the Swedish Cancer Institute.
: This study was a retrospective analysis of secondary data, and therefore, ethics approval was not required. All data were de-identified and handled in compliance with HIPAA requirements.
